Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
doi:10.1111/j.1399-3011.1992.tb00309.x
Glucagon-like peptide 1 treatment reverses vascular remodelling by downregulating matrix metalloproteinase 1 expression through inhibition of the ERK1/2/NF-B signalling pathway
With coverage becoming more widespread, affordability barriers diminish and treatment uptake rises significantly, thereby driving the growth of the GLP-1 receptor agonist market
Interplay between frailty and cardiometabolic disorders: from pathophysiology to clinical implications
US$ 26.07
US$ 23.25
US$ 25.69
US$ 22.93
US$ 26.22
US$ 20.39
US$ 22.71
US$ 26.41
US$ 22.13
US$ 21.17
